CYP20A1 and laryngotracheoesophageal cleft: We found that rs2762934 and rs6068816 in CYP24A1 decreased the risk of LC development in males and SCLC respectively, and CYP20A1 rs2043449 was identified as a risk factor of LC development in males, III‐IV stage, and SCLC subgroups.